BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu YY, Liang XS. Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA. World J Hepatol 2018; 10(9): 603-611 [PMID: 30310538 DOI: 10.4254/wjh.v10.i9.603]
URL: https://www.wjgnet.com/1948-5182/full/v10/i9/603.htm
Number Citing Articles
1
Emilia Hadziyannis, Stephanos Hadziyannis. Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis BExpert Review of Gastroenterology & Hepatology 2020; 14(4): 243 doi: 10.1080/17474124.2020.1738219
2
Takako Inoue, Yasuhito Tanaka. Comprehensive Guide to Hepatitis Advances2023; : 31 doi: 10.1016/B978-0-323-98368-6.00009-4
3
Dheyaa Hussein Mohsin, Muthana Saleh Mashkour, Fataneh Fatemi. Design of aptamer-based sensing platform using gold nanoparticles functionalized reduced graphene oxide for ultrasensitive detection of Hepatitis B virusChemical Papers 2021; 75(1): 279 doi: 10.1007/s11696-020-01292-1
4
Takako Inoue, Yasuhito Tanaka. The Role of Hepatitis B Core-Related AntigenGenes 2019; 10(5): 357 doi: 10.3390/genes10050357
5
Guanghua Ma, Bin Lou, Feifei Lv, Dejian Zhao, Hui Chen, Xianfei Ye, Yu Chen. HBcrAg, pg RNA and HBsAg dynamically supervise the seroconversion of HBsAg with anti-viral therapyClinica Chimica Acta 2020; 501: 264 doi: 10.1016/j.cca.2019.10.049
6
Chun-Rui Wang, Xiao-qin Liu, Wei Shen, Guo-Chao Zhong, Hu Li, Qiao Tang, Yu-Xing Liu, Peng Hu. Profiles of HBcrAg and pgRNA in Pregnant Women With Chronic HBV Under Different Disease Phases and Antiviral ProphylaxisOpen Forum Infectious Diseases 2024; 11(5) doi: 10.1093/ofid/ofae241
7
Beibei Lou, Yanfei Liu, Meilin Shi, Jun Chen, Ke Li, Yifu Tan, Liwei Chen, Yuwei Wu, Ting Wang, Xiaoqin Liu, Ting Jiang, Dongming Peng, Zhenbao Liu. Aptamer-based biosensors for virus protein detectionTrAC Trends in Analytical Chemistry 2022; 157: 116738 doi: 10.1016/j.trac.2022.116738
8
Mohammad Ghorbani, Zahra Daryabour, Rahman Shokri, Vahid Kia, Zohreh Sharifi, Mahdi Paryan. Optimization and Application of Quantitative In-House ELISA for Diagnosis of HBsAg and its Correlation with Commercial ELISA and Molecular KitsHepatitis Monthly 2023; (In Press) doi: 10.5812/hepatmon-133150
9
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis BClinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
10
Chun-Rui Wang, Guo-Chao Zhong, Zhi-Wei Chen, Peng Hu. A Nomogram for Predicting Non-Rebound in HBV-Infected Pregnant Women With Mother-to-Child Transmission PreventionFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.746759
11
Andreas Laras, Margarita Papatheodoridi, Eleni Panopoulou, George V. Papatheodoridis, Stephanos J. Hadziyannis, Emilia Hadziyannis. Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis BVirology Journal 2022; 19(1) doi: 10.1186/s12985-022-01749-7
12
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka. Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapyClinical and Molecular Hepatology 2023; 29(4): 851 doi: 10.3350/cmh.2022.0434
13
Magda Rybicka, Krzysztof Piotr Bielawski. Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus InfectionMicroorganisms 2020; 8(9): 1416 doi: 10.3390/microorganisms8091416
14
Anna Kramvis, Kyong-Mi Chang, Maura Dandri, Patrizia Farci, Dieter Glebe, Jianming Hu, Harry L. A. Janssen, Daryl T. Y. Lau, Capucine Penicaud, Teresa Pollicino, Barbara Testoni, Florian Van Bömmel, Ourania Andrisani, Maria Beumont-Mauviel, Timothy M. Block, Henry L. Y. Chan, Gavin A. Cloherty, William E. Delaney, Anna Maria Geretti, Adam Gehring, Kathy Jackson, Oliver Lenz, Mala K. Maini, Veronica Miller, Ulrike Protzer, Jenny C. Yang, Man-Fung Yuen, Fabien Zoulim, Peter A. Revill. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlookNature Reviews Gastroenterology & Hepatology 2022; 19(11): 727 doi: 10.1038/s41575-022-00649-z
15
Ian Baudi, Takako Inoue, Yasuhito Tanaka. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGiInternational Journal of Molecular Sciences 2020; 21(3): 949 doi: 10.3390/ijms21030949
16
Shuya Matsuda, Shinya Maekawa, Yasuyuki Komiyama, Natsuko Nakakuki, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Fumitake Amemiya, Hiroko Shindo, Shinichi Takano, Mitsuharu Fukasawa, Tatsuya Yamaguchi, Yasuhiro Nakayama, Taisuke Inoue, Tadashi Sato, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto. Deep sequencing analysis of serum hepatitis B virus‐RNA during nucleot(s)ide analogue therapyHepatology Research 2021; 51(1): 39 doi: 10.1111/hepr.13574
17
Dan-Ying Cheng, Zhi-Min Zhao, Gang Wan, Huan-Wei Zheng, Jia-Quan Huang, Cheng-Hai Liu, Hui-Chun Xing. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosisHepatobiliary & Pancreatic Diseases International 2022; 21(5): 479 doi: 10.1016/j.hbpd.2022.03.007
18
Xiu-Mei Chi, Xiao-Mei Wang, Zhong-Feng Wang, Rui-Hong Wu, Xiu-Zhu Gao, Hong-Qin Xu, Yan-Hua Ding, Jun-Qi Niu. Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis BWorld Journal of Gastroenterology 2021; 27(40): 6927-6938 doi: 10.3748/wjg.v27.i40.6927
19
Rui Deng, Shi Liu, Sheng Shen, Haitao Guo, Jian Sun. Circulating HBV RNA: From biology to clinical applicationsHepatology 2022; 76(5): 1520 doi: 10.1002/hep.32479